Global Cancer Microbiome Sequencing Market Landscape 2023-2027: Decreasing Sequencing Costs, Rise in Research & Development - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cancer Microbiome Sequencing Global Market Outlook to 2027" report has been added to ResearchAndMarkets.com's offering.

The global cancer microbiome sequencing market is poised for remarkable growth during the forecast period from 2023 to 2027. Key factors driving this growth include the escalating prevalence of cancer and the increasing recognition of the microbiome's potential within the field of oncology.

Factors Fueling Market Growth:

1. Decreasing Sequencing Costs: The cost of microbiome sequencing is reducing, making it more accessible for research and clinical applications.

2. Rise in Research & Development: Increasing research efforts aimed at understanding the impact of microbiomes on cancer have propelled the market.

3. Surge in Cancer Cases: The global increase in various cancer types, driven by factors like unhealthy lifestyles and environmental exposures, contributes to the demand for cancer microbiome sequencing.

4. Clinical Trials & Diagnostic Tools: The growing number of clinical trials and the development of novel diagnostic tools based on microbiome analysis support market expansion.

5. Biotechnology Investments: Biotech companies' investments in microbiome-related research and development foster advancements in the field.

6. Emerging Submarkets: The market presents promising potential in various submarkets related to microbiome analysis in cancer research and diagnostics.

Prevalence of Cancer Driving Demand: The rising prevalence of cancers such as lung, cervical, breast, skin, and throat cancers is a significant driver of market growth. According to the World Health Organization (WHO), cancer is a leading cause of death globally, with around 10 million reported deaths in 2020. Early detection is crucial for effective treatment, and microbiome sequencing holds promise in contributing to early diagnosis.

Researcher Interest & Biotech Support: Researchers are increasingly exploring the role of microbiomes in cancer, and biotechnology companies are providing support for such investigations. Insights gained from microbiome analysis aid in identifying novel cancer biomarkers and developing sequencing-based products for clinical use.

Market Segmentation: The global cancer microbiome sequencing market is segmented by components (kits & assays, software, services), technology (next-generation sequencing, polymerase chain reaction), application (translational research, clinical diagnostics), end-users (biotech & pharmaceutical companies, academic & research institutions, hospitals & clinics), and geography. The United States is expected to be a key market due to high cancer incidence and robust research activities.

Leading Market Players: Prominent companies contributing to the cancer microbiome sequencing market include Illumina, Eurofins Scientific, QIAGEN, Thermo Fischer Scientific, Oxford Nanopore Technologies, OraSure Technologies, Pacific Biosciences of California, Psomagen, Prescient Medicine Holdings, and Micronoma Inc.

Conclusion: With the convergence of growing cancer incidences, increasing awareness of microbiome contributions, and research advancements in sequencing technologies, the global cancer microbiome sequencing market is set for substantial growth. Researchers, biotechnology companies, and healthcare stakeholders continue to collaborate to unlock the potential of microbiome analysis in cancer detection, diagnosis, and treatment.

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cancer Microbiome Sequencing Market

5. Voice of Customer

6. Global Cancer Microbiome Sequencing Market Outlook

7. North America Cancer Microbiome Sequencing Market Outlook

8. Europe Cancer Microbiome Sequencing Market Outlook

9. Asia-Pacific Cancer Microbiome Sequencing Market Outlook

10. South America Cancer Microbiome Sequencing Market Outlook

11. Middle East and Africa Cancer Microbiome Sequencing Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape

15. Strategic Recommendations

A selection of companies mentioned in this report includes:

• Illumina, Inc.
• Eurofins Scientific SE
• QIAGEN NV
• Thermo Fischer Scientific, Inc.
• Oxford Nanopore Technologies plc
• OraSure Technologies, Inc.
• Pacific Biosciences of California, Inc.
• Psomagen, Inc
• Prescient Medicine Holdings, Inc.
• Micronoma Inc.

For more information about this report visit https://www.researchandmarkets.com/r/7gg8ka

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.